↓ Skip to main content

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP

Overview of attention for article published in Drug Design, Development and Therapy, May 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent
1 patent
video
1 YouTube creator

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
Published in
Drug Design, Development and Therapy, May 2022
DOI 10.2147/dddt.s358989
Pubmed ID
Authors

Lijing Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 8%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Lecturer > Senior Lecturer 2 4%
Student > Postgraduate 2 4%
Other 3 6%
Unknown 30 63%
Readers by discipline Count As %
Medicine and Dentistry 10 21%
Chemistry 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Agricultural and Biological Sciences 1 2%
Other 1 2%
Unknown 29 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2024.
All research outputs
#8,494,607
of 25,958,626 outputs
Outputs from Drug Design, Development and Therapy
#601
of 2,288 outputs
Outputs of similar age
#161,464
of 450,640 outputs
Outputs of similar age from Drug Design, Development and Therapy
#5
of 36 outputs
Altmetric has tracked 25,958,626 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,288 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.